Kyntra Bio, Inc.
KYNBNASDAQHealthcareBiotechnology
As of Oct 22, 2026 close
- Market cap
- $21.13M
- P/E (TTM)
- 0.16
- Forward P/E
- -
- Dividend yield
- -
- 52-week range
- $4.85$11.65
- Volume (live)
- -
- Avg. volume (3M)
- 24.28K
Kyntra Bio (KYNB) Stock Price & Financial Analysis
Kyntra Bio Stock Price Chart
Loading chart...
Financial Metrics & Key Statistics
Fundamental metrics, valuation ratios, and profitability indicators
| Day's Range | $5.16 - $5.16 |
|---|---|
| 52-Week High | $11.65 |
| 52-Week Low | $4.85 |
| Open | $5.16 |
| Volume (last close) | 9.54K |
| Average Volume (3M) | 24.28K |
| Revenue (TTM) | 4.62M |
|---|---|
| Net Income (TTM) | 131.03M |
| Free Cash Flow (TTM) | -38.06M |
| EPS (TTM) | $32.38 |
| Profit Margin | 2837.97% |
| Operating Margin | -1089.04% |
| Annual Dividend | $0.00 |
|---|---|
| Dividend Yield | 0.00% |
| Payout Ratio | 0.00% |
| Market Cap | 21.13M |
|---|---|
| Shares Outstanding | 4.05M |
| P/E Ratio (TTM) | 0.16 |
| Price to Sales (P/S) | 4.58 |
| Price to Book (P/B) | -2.59 |
| EV/EBITDA | 0.35 |
| 50-Day MA | $7.06 |
|---|---|
| 200-Day MA | $7.28 |
| 1-Year Change | −51.26% |
Source: Market prices and company fundamentals. Data as of Oct 22, 2026. Data sources and methodology
Kyntra Bio at a Glance
As of the Oct 22, 2026 close, Kyntra Bio (KYNB) has a market capitalization of $21.13M. The stock trades at 0.2× trailing earnings and 4.6× sales. Over the trailing twelve months it earned $131.03M on revenue of $4.62M (a 2838.0% profit margin) and burned $38.06M of free cash flow. Revenue fell 37.1% year over year.
As of its latest reported balance sheet, it holds $50.64M in cash and securities against $0.00 of debt, a net cash position of $50.64M.
Kyntra Bio does not currently pay a dividend.
The share price is down 51.3% over the past year. At $5.22 (the Oct 22, 2026 close) it sits near the bottom of its 52-week range of $4.85 to $11.65, below its 200-day moving average of $7.28.
Based on 5 professional analyst ratings from the past 90 days, the consensus is Buy with an average price target of $39.67, 660.0% above the Oct 22, 2026 close.
Frequently Asked Questions About Kyntra Bio
What is the current stock price for KYNB?
As of the Oct 22, 2026 close, KYNB stock trades at $5.22. The 52-week range is $4.85–$11.65, with a day range of $5.16–$5.16.
What is the P/E ratio for KYNB?
As of the Oct 22, 2026 close, Kyntra Bio's trailing twelve-month (TTM) P/E ratio is 0.2, meaning investors pay $0.2 for every $1 of annual earnings. Kyntra Bio operates in the Healthcare sector.
Does KYNB pay dividends?
Kyntra Bio does not currently pay a regular dividend. The company retains its earnings to reinvest in the business. Check the Dividends tab for historical dividend information.
What do analysts recommend for KYNB?
Based on ratings from 5 professional analysts over the last 90 days, the consensus for KYNB is Buy. The average 12-month price target is $39.67, a 660.0% upside from the Oct 22, 2026 close of $5.22.
What is the market cap of KYNB?
As of the Oct 22, 2026 close, Kyntra Bio's market capitalization is $21.1M, classifying it as a micro-cap company. Kyntra Bio operates in the Healthcare sector within the Biotechnology industry.